Compare Bandhan BSE Healthcare Index Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.03
1.99
NAV
₹9.90
₹38.69
Fund Started
21 Aug 2024
25 Jun 2018
Fund Size
₹16.00 Cr
₹6293.14 Cr
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
Exit load of 1% if redeemed within 15 days.
1 Year
2.25%
4.37%
3 Year
-
25.91%
5 Year
-
15.56%
Equity
100.01%
97.62%
Cash
-0.01%
2.35%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 14.45% |
Dr. Reddy's Laboratories Ltd. | 5.82% |
Apollo Hospitals Enterprise Ltd. | 5.78% |
Divi's Laboratories Ltd. | 5.77% |
Max Healthcare Institute Ltd. | 5.42% |
Cipla Ltd. | 5.27% |
Lupin Ltd. | 4.27% |
Torrent Pharmaceuticals Ltd. | 3.26% |
Fortis Healthcare Ltd. | 3.15% |
Laurus Labs Ltd. | 2.94% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
21 Aug 2024
25 Jun 2018
